Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Oct;62(10):4440–4444. doi: 10.1128/iai.62.10.4440-4444.1994

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.

S C Szu 1, D N Taylor 1, A C Trofa 1, J D Clements 1, J Shiloach 1, J C Sadoff 1, D A Bryla 1, J B Robbins 1
PMCID: PMC303128  PMID: 7927707

Abstract

To improve its immunogenicity for children and adults and to make it suitable for routine immunization of infants against typhoid fever, the capsular polysaccharide of Salmonella typhi (Vi) was bound to the B subunit of the heat-labile toxin (LT-B) of Escherichia coli or the recombinant exoprotein A (rEPA) of Pseudomonas aeruginosa. The conjugates elicited higher levels of antibodies (micrograms per milliliter of serum) in mice and in guinea pigs than did Vi and, unlike Vi alone, elicited booster antibody responses in both species. In adult volunteers, Vi-LT-B and Vi-rEPA, respectively, elicited higher levels of antibodies than Vi alone after the first injection (4.74 versus 1.77 and 4.91 versus 1.77; P < 0.005) and 26 weeks later (2.32 and 2.69 versus 0.54; P < 0.04); a second injection of the conjugates did not elicit a booster response of Vi antibodies. None of the 51 vaccinees had fever or significant local reactions. Vi-rEPA elicited slightly higher levels of Vi antibodies than did Vi-LT-B at all intervals after injection, but these differences were not significant. Each conjugate elicited antibodies to its carrier protein. The antibody responses elicited in adults by Vi bound to LT-B and rEPA are similar to those of other polysaccharide-protein conjugates. These conjugates promise to be an improved Vi vaccine. Studies of Vi conjugates with adults and infants in areas where typhoid is endemic are planned.

Full text

PDF
4440

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acharya I. L., Lowe C. U., Thapa R., Gurubacharya V. L., Shrestha M. B., Cadoz M., Schulz D., Armand J., Bryla D. A., Trollfors B. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med. 1987 Oct 29;317(18):1101–1104. doi: 10.1056/NEJM198710293171801. [DOI] [PubMed] [Google Scholar]
  2. Anand A. C., Kataria V. K., Singh W., Chatterjee S. K. Epidemic multiresistant enteric fever in eastern India. Lancet. 1990 Feb 10;335(8685):352–352. doi: 10.1016/0140-6736(90)90635-i. [DOI] [PubMed] [Google Scholar]
  3. Carlsson J., Drevin H., Axén R. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J. 1978 Sep 1;173(3):723–737. doi: 10.1042/bj1730723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Claesson B. A., Schneerson R., Robbins J. B., Johansson J., Lagergard T., Taranger J., Bryla D., Levi L., Cramton T., Trollfors B. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr. 1989 Jan;114(1):97–100. doi: 10.1016/s0022-3476(89)80611-0. [DOI] [PubMed] [Google Scholar]
  5. Clements J. D., Finkelstein R. A. Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures. Infect Immun. 1979 Jun;24(3):760–769. doi: 10.1128/iai.24.3.760-769.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clements J. D., Yancey R. J., Finkelstein R. A. Properties of homogeneous heat-labile enterotoxin from Escherichia coli. Infect Immun. 1980 Jul;29(1):91–97. doi: 10.1128/iai.29.1.91-97.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colon A. R., Gross D. R., Tamer M. A. Typhoid fever in children. Pediatrics. 1975 Oct;56(4):606–609. [PubMed] [Google Scholar]
  8. ELLMAN G. L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  9. Edelman R., Levine M. M. Summary of an international workshop on typhoid fever. Rev Infect Dis. 1986 May-Jun;8(3):329–349. doi: 10.1093/clinids/8.3.329. [DOI] [PubMed] [Google Scholar]
  10. Elson C. O., Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol. 1984 Jun;132(6):2736–2741. [PubMed] [Google Scholar]
  11. Fass R., van de Walle M., Shiloach A., Joslyn A., Kaufman J., Shiloach J. Use of high density cultures of Escherichia coli for high level production of recombinant Pseudomonas aeruginosa exotoxin A. Appl Microbiol Biotechnol. 1991 Oct;36(1):65–69. doi: 10.1007/BF00164700. [DOI] [PubMed] [Google Scholar]
  12. Fattom A., Schneerson R., Watson D. C., Karakawa W. W., Fitzgerald D., Pastan I., Li X., Shiloach J., Bryla D. A., Robbins J. B. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect Immun. 1993 Mar;61(3):1023–1032. doi: 10.1128/iai.61.3.1023-1032.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ferreccio C., Levine M. M., Manterola A., Rodriguez G., Rivara I., Prenzel I., Black R. E., Mancuso T., Bulas D. Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years. J Pediatr. 1984 Jun;104(6):899–901. doi: 10.1016/s0022-3476(84)80492-8. [DOI] [PubMed] [Google Scholar]
  14. Gilman R. H., Terminel M., Levine M. M., Hernandez-Mendoza P., Hornick R. B. Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet. 1975 May 31;1(7918):1211–1213. doi: 10.1016/s0140-6736(75)92194-7. [DOI] [PubMed] [Google Scholar]
  15. Goldstein F. W., Chumpitaz J. C., Guevara J. M., Papadopoulou B., Acar J. F., Vieu J. F. Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis. 1986 Feb;153(2):261–266. doi: 10.1093/infdis/153.2.261. [DOI] [PubMed] [Google Scholar]
  16. Hoffman S. L., Edman D. C., Punjabi N. H., Lesmana M., Cholid A., Sundah S., Harahap J. Bone marrow aspirate culture superior to streptokinase clot culture and 8 ml 1:10 blood-to-broth ratio blood culture for diagnosis of typhoid fever. Am J Trop Med Hyg. 1986 Jul;35(4):836–839. doi: 10.4269/ajtmh.1986.35.836. [DOI] [PubMed] [Google Scholar]
  17. Johnson A. O., Aderele W. I. Enteric fever in childhood. J Trop Med Hyg. 1981 Feb;84(1):29–35. [PubMed] [Google Scholar]
  18. Kaye D., Palmieri M., Eyckmans L., Rocha H., Hook E. W. Comparison of bile and trypticase soy broth for isolation Salmonella from blood. Am J Clin Pathol. 1966 Sep;46(3):408–410. doi: 10.1093/ajcp/46.3_ts.408. [DOI] [PubMed] [Google Scholar]
  19. Keitel W. A., Bond N. L., Zahradnik J. M., Cramton T. A., Robbins J. B. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine. 1994;12(3):195–199. doi: 10.1016/0264-410x(94)90194-5. [DOI] [PubMed] [Google Scholar]
  20. Klotz S. A., Jorgensen J. H., Buckwold F. J., Craven P. C. Typhoid fever. An epidemic with remarkably few clinical signs and symptoms. Arch Intern Med. 1984 Mar;144(3):533–537. doi: 10.1001/archinte.144.3.533. [DOI] [PubMed] [Google Scholar]
  21. Klugman K. P., Gilbertson I. T., Koornhof H. J., Robbins J. B., Schneerson R., Schulz D., Cadoz M., Armand J. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet. 1987 Nov 21;2(8569):1165–1169. doi: 10.1016/s0140-6736(87)91316-x. [DOI] [PubMed] [Google Scholar]
  22. LANDY M. Studies on Vi antigen. VI. Immunization of human beings with purified Vi antigen. Am J Hyg. 1954 Jul;60(1):52–62. doi: 10.1093/oxfordjournals.aje.a119703. [DOI] [PubMed] [Google Scholar]
  23. LANDY M. Studies on Vi antigen. VII. Characteristics of the immune response in the mouse. Am J Hyg. 1957 Jan;65(1):81–93. doi: 10.1093/oxfordjournals.aje.a119858. [DOI] [PubMed] [Google Scholar]
  24. McCall C. E., Martin W. T., Boring J. R. Efficiency of cultures of rectal swabs and faecal specimens in detecting salmonella carriers: correlation with numbers of salmonellas excreted. J Hyg (Lond) 1966 Sep;64(3):261–269. doi: 10.1017/s0022172400040547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mulligan T. O. Typhoid fever in young children. Br Med J. 1971 Dec 11;4(5788):665–667. doi: 10.1136/bmj.4.5788.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nolan C. M., LaBorde E. A., Howell R. T., Robbins J. B. Identification of Salmonella typhi in faecal specimens by an antiserum-agar method. J Med Microbiol. 1980 May;13(2):373–377. doi: 10.1099/00222615-13-2-373. [DOI] [PubMed] [Google Scholar]
  27. Robbins J. B., Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis. 1990 May;161(5):821–832. doi: 10.1093/infdis/161.5.821. [DOI] [PubMed] [Google Scholar]
  28. Robbins J. D., Robbins J. B. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis. 1984 Sep;150(3):436–449. doi: 10.1093/infdis/150.3.436. [DOI] [PubMed] [Google Scholar]
  29. Ryan C. A., Hargrett-Bean N. T., Blake P. A. Salmonella typhi infections in the United States, 1975-1984: increasing role of foreign travel. Rev Infect Dis. 1989 Jan-Feb;11(1):1–8. doi: 10.1093/clinids/11.1.1. [DOI] [PubMed] [Google Scholar]
  30. Sarnaik S., Kaplan J., Schiffman G., Bryla D., Robbins J. B., Schneerson R. Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia. Pediatr Infect Dis J. 1990 Mar;9(3):181–186. doi: 10.1097/00006454-199003000-00007. [DOI] [PubMed] [Google Scholar]
  31. Schneerson R., Robbins J. B., Parke J. C., Jr, Bell C., Schlesselman J. J., Sutton A., Wang Z., Schiffman G., Karpas A., Shiloach J. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun. 1986 May;52(2):519–528. doi: 10.1128/iai.52.2.519-528.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Simanjuntak C. H., Paleologo F. P., Punjabi N. H., Darmowigoto R., Soeprawoto, Totosudirjo H., Haryanto P., Suprijanto E., Witham N. D., Hoffman S. L. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet. 1991 Oct 26;338(8774):1055–1059. doi: 10.1016/0140-6736(91)91910-m. [DOI] [PubMed] [Google Scholar]
  33. Stone A. L., Szu S. C. Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever. J Clin Microbiol. 1988 Apr;26(4):719–725. doi: 10.1128/jcm.26.4.719-725.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Szu S. C., Li X. R., Schneerson R., Vickers J. H., Bryla D., Robbins J. B. Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi. Infect Immun. 1989 Dec;57(12):3823–3827. doi: 10.1128/iai.57.12.3823-3827.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Szu S. C., Li X. R., Stone A. L., Robbins J. B. Relation between structure and immunologic properties of the Vi capsular polysaccharide. Infect Immun. 1991 Dec;59(12):4555–4561. doi: 10.1128/iai.59.12.4555-4561.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Szu S. C., Stone A. L., Robbins J. D., Schneerson R., Robbins J. B. Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals. J Exp Med. 1987 Nov 1;166(5):1510–1524. doi: 10.1084/jem.166.5.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Szu S. C., Zon G., Schneerson R., Robbins J. B. Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process. Carbohydr Res. 1986 Sep 1;152:7–20. doi: 10.1016/s0008-6215(00)90283-0. [DOI] [PubMed] [Google Scholar]
  38. Tacket C. O., Ferreccio C., Robbins J. B., Tsai C. M., Schulz D., Cadoz M., Goudeau A., Levine M. M. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis. 1986 Aug;154(2):342–345. doi: 10.1093/infdis/154.2.342. [DOI] [PubMed] [Google Scholar]
  39. Thisyakorn U., Mansuwan P., Taylor D. N. Typhoid and paratyphoid fever in 192 hospitalized children in Thailand. Am J Dis Child. 1987 Aug;141(8):862–865. doi: 10.1001/archpedi.1987.04460080048025. [DOI] [PubMed] [Google Scholar]
  40. Topley J. M. Mild typhoid fever. Arch Dis Child. 1986 Feb;61(2):164–167. doi: 10.1136/adc.61.2.164. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES